BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 29330279)

  • 1. Rare cause of isolated severe coagulation failure in cirrhosis: traditional healing with fenugreek.
    Philips CA; Augustine P
    BMJ Case Rep; 2018 Jan; 2018():. PubMed ID: 29330279
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The accuracy of the International Normalized Ratio and the American College of Chest Physicians recommendations on the use of vitamin K to reverse over-anticoagulation: a rebuttal.
    Schulman S; Crowther M; Holbrook A
    J Thromb Haemost; 2013 Mar; 11(3):566-7. PubMed ID: 23279332
    [No Abstract]   [Full Text] [Related]  

  • 3. The accuracy of the International Normalized Ratio and the American College of Chest Physicians recommendations on the use of vitamin K to reverse over-anticoagulation.
    Tripodi A; Moia M
    J Thromb Haemost; 2012 Oct; 10(10):2207-8. PubMed ID: 22882756
    [No Abstract]   [Full Text] [Related]  

  • 4. Coagulopathy in a patient with nephrotic syndrome.
    Ghanny S; Ross C; Chan AK; Chan HH
    Am J Hematol; 2010 Sep; 85(9):708-10. PubMed ID: 20669179
    [No Abstract]   [Full Text] [Related]  

  • 5. Prostate cancer: beware of disseminated intravascular coagulation.
    Desai M; John B; Evans G; Eddy B
    BMJ Case Rep; 2015 Mar; 2015():. PubMed ID: 25819815
    [TBL] [Abstract][Full Text] [Related]  

  • 6. AGA Clinical Practice Update: Coagulation in Cirrhosis.
    O'Leary JG; Greenberg CS; Patton HM; Caldwell SH
    Gastroenterology; 2019 Jul; 157(1):34-43.e1. PubMed ID: 30986390
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of the efficacy of a novel tailored vitamin K dosing regimen in lowering the International Normalised Ratio in over-anticoagulated patients: a randomised clinical trial.
    Kampouraki E; Avery PJ; Wynne H; Biss T; Hanley J; Talks K; Kamali F
    Br J Haematol; 2017 Sep; 178(5):800-809. PubMed ID: 28771671
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of Vitamin K Administration on INR Changes and Bleeding Events Among Patients With Cirrhosis.
    Meyer AV; Green M; Pautler HM; Korenblat K; Deal EN; Thoelke MS
    Ann Pharmacother; 2016 Feb; 50(2):113-7. PubMed ID: 26586854
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low-dose oral vitamin K therapy for the management of asymptomatic patients with elevated international normalized ratios: a brief review.
    Wilson SE; Watson HG; Crowther MA
    CMAJ; 2004 Mar; 170(5):821-4. PubMed ID: 14993179
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vitamin K for improved anticoagulation control in patients receiving warfarin.
    Mahtani KR; Heneghan CJ; Nunan D; Roberts NW
    Cochrane Database Syst Rev; 2014 May; (5):CD009917. PubMed ID: 24832594
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The use of vitamin K in patients on anticoagulant therapy: a practical guide.
    Hanslik T; Prinseau J
    Am J Cardiovasc Drugs; 2004; 4(1):43-55. PubMed ID: 14967065
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effectiveness of intravenous vitamin K in correcting cirrhosis-associated coagulopathy.
    Rivosecchi RM; Kane-Gill SL; Garavaglia J; MacLasco A; Johnson H
    Int J Pharm Pract; 2017 Dec; 25(6):463-465. PubMed ID: 28211589
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Coagulation disorders in cirrhosis].
    Téllez-Avila FI; Chávez-Tapia NC; Torre-Delgadillo A
    Rev Invest Clin; 2007; 59(2):153-60. PubMed ID: 17633804
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Route of vitamin K administration for elevated INRs in the acute inpatient setting.
    Mersfelder TL
    Med Health R I; 2005 Dec; 88(12):441-2. PubMed ID: 16408720
    [No Abstract]   [Full Text] [Related]  

  • 15. An oral vitamin K protocol to reverse over-anticoagulation in patients presenting with an International Normalised Ratio above 10.0.
    Denas G; Cucchini U; Iliceto S; Pengo V
    Thromb Haemost; 2009 Feb; 101(2):410-1. PubMed ID: 19190831
    [No Abstract]   [Full Text] [Related]  

  • 16. Differential Kinetics of Coagulation Factors and Natural Anticoagulants in Patients with Liver Cirrhosis: Potential Clinical Implications.
    Tischendorf M; Miesbach W; Chattah U; Chattah Z; Maier S; Welsch C; Zeuzem S; Lange CM
    PLoS One; 2016; 11(5):e0155337. PubMed ID: 27171213
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dietary vitamin K intake and anticoagulation in elderly patients.
    Rohde LE; de Assis MC; Rabelo ER
    Curr Opin Clin Nutr Metab Care; 2007 Jan; 10(1):1-5. PubMed ID: 17143047
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Real world usage of PCC to "rapidly" correct warfarin induced coagulopathy.
    Toth P; van Veen JJ; Robinson K; Maclean RM; Hampton KK; Laidlaw S; Makris M
    Blood Transfus; 2013 Oct; 11(4):500-5. PubMed ID: 23114527
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk of further decompensation/mortality in patients with cirrhosis and ascites as the first single decompensation event.
    Balcar L; Tonon M; Semmler G; Calvino V; Hartl L; Incicco S; Jachs M; Bauer D; Hofer BS; Gambino CG; Accetta A; Brocca A; Trauner M; Mandorfer M; Piano S; Reiberger T;
    JHEP Rep; 2022 Aug; 4(8):100513. PubMed ID: 35845294
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral vitamin K versus placebo to correct excessive anticoagulation in patients receiving warfarin: a randomized trial.
    Crowther MA; Ageno W; Garcia D; Wang L; Witt DM; Clark NP; Blostein MD; Kahn SR; Vesely SK; Schulman S; Kovacs MJ; Rodger MA; Wells P; Anderson D; Ginsberg J; Selby R; Siragusa S; Silingardi M; Dowd MB; Kearon C
    Ann Intern Med; 2009 Mar; 150(5):293-300. PubMed ID: 19258557
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.